News and Events
The University of Michigan Rogel Cancer Center has partnered with 69 other National Cancer Institute-designated cancer centers to issue a statement urging for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer.
Media contact: Jessica Webster-Sendra, 734-764-2220 | Patients may contact Cancer AnswerLine, 800-865-1125
ANN ARBOR, Michigan — With the recently announced FDA approval of Kymriah to treat adults with lymphoma, the University of Michigan Rogel Cancer Center is the first center in Michigan to offer all currently available CAR T-cell therapies.
Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Clinical Oncology (ASCO) Annual meeting from Friday, June 1 through Tuesday, June 5. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.